Apyx Medical Corp financial data

Symbol
APYX on Nasdaq
Location
5115 Ulmerton Road, Clearwater, FL
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 521 % -3.57%
Quick Ratio 80.4 % -11.8%
Debt-to-equity 466 % +147%
Return On Equity -158 % -33.7%
Return On Assets -28.3 % +31.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 37.8M shares +9.17%
Common Stock, Shares, Outstanding 37.8M shares +9.09%
Entity Public Float 43.1M USD -74.3%
Common Stock, Value, Issued 38K USD +8.57%
Weighted Average Number of Shares Outstanding, Basic 40.7M shares +17.6%
Weighted Average Number of Shares Outstanding, Diluted 34.6M shares +0.12%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 46.5M USD -5.14%
Research and Development Expense 3.89M USD -31%
Operating Income (Loss) -12.3M USD +45.5%
Nonoperating Income (Expense) -4.74M USD -12.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -17M USD +40.4%
Income Tax Expense (Benefit) 247K USD -2%
Net Income (Loss) Attributable to Parent -17.3M USD +39.2%
Earnings Per Share, Basic 0 USD/shares +46.3%
Earnings Per Share, Diluted 0 USD/shares -74.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 29.3M USD -10.3%
Accounts Receivable, after Allowance for Credit Loss, Current 11.2M USD -11.5%
Inventory, Net 8.19M USD -12.1%
Assets, Current 49.9M USD -11.9%
Property, Plant and Equipment, Net 2.05M USD +6.78%
Operating Lease, Right-of-Use Asset 4.46M USD -9.54%
Other Assets, Noncurrent 1.72M USD -4.86%
Assets 58.2M USD -11%
Accounts Payable, Current 2.89M USD +23.2%
Employee-related Liabilities, Current 1.28M USD
Accrued Liabilities, Current 7.28M USD
Contract with Customer, Liability, Current 515K USD -51.1%
Liabilities, Current 10.6M USD -0.69%
Contract with Customer, Liability, Noncurrent 1.19M USD -6.06%
Operating Lease, Liability, Noncurrent 4.29M USD -8.62%
Other Liabilities, Noncurrent 292K USD +52.1%
Liabilities 50.7M USD +0.52%
Retained Earnings (Accumulated Deficit) -85.8M USD -25.2%
Stockholders' Equity Attributable to Parent 7.25M USD -50.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 7.46M USD -50%
Liabilities and Equity 58.2M USD -11%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -702K USD +88.9%
Net Cash Provided by (Used in) Financing Activities 25K USD
Net Cash Provided by (Used in) Investing Activities -55K USD -57.1%
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 37.8M shares +9.09%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -730K USD +88.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 32.7M USD +76.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.15M USD -2.55%
Deferred Tax Assets, Valuation Allowance 20.7M USD +25.9%
Deferred Tax Assets, Gross 22.1M USD +22.3%
Operating Lease, Liability 4.82M USD -8.11%
Payments to Acquire Property, Plant, and Equipment 55K USD +57.1%
Lessee, Operating Lease, Liability, to be Paid 6.99M USD -10.3%
Property, Plant and Equipment, Gross 5.34M USD +6.04%
Operating Lease, Liability, Current 378K USD +20.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 824K USD +2.36%
Lessee, Operating Lease, Liability, to be Paid, Year One 797K USD +2.44%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.17M USD -14.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 852K USD +2.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 764K USD -11.2%
Additional Paid in Capital 93.1M USD +11.7%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 138K USD -12.1%
Deferred Tax Assets, Net of Valuation Allowance 1.36M USD -14.5%
Share-based Payment Arrangement, Expense 2.81M USD -36.8%
Interest Expense 4.52M USD +479%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%